fbpx

Category Archives for "Press Releases"

Stem Cell Training Achieves 2015 Goal, Training 402 Physicians in 27 Cities Worldwide

Global Stem Cells Group announces that its subsidiary, Stem Cell Training achieved its 2015 goal in August, training 402 physicians in 27 cities worldwide.

stem cell therapies,EuroMedicom,stem cell medicine,global stem cells group,medical tourism,regenestem,

Stem Cell Training

Stem Cell Training has emerged as a worldwide leader in training physicians in these important protocols.

Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. is proud to announce that it has achieved its 2015 goal in August, having trained 402 physicians in 27 cities worldwide in minimally invasive techniques for harvesting stem cells from adipose tissue.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process through an intensive, hands-on training session that arms participants with clinical protocols and state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells.

The announcement confirms Global Stem Cells Group’s effort and commitment to empower physicians with the skills necessary to implement regenerative medicine techniques at their places of practice.

“We achieved our goal for 2015 in just eight months, proving the potential the stem cell industry holds,” says Global Stem Cells Group founder and CEO Benito Novas. “The interest keeps on growing, and Stem Cell Training has emerged as a worldwide leader in training physicians in these important protocols.”

To find out more about stem cell training courses for physicians and qualified medical professionals, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About Stem Cell Training, Inc.:

Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow. The objective of the training is to bridge the gap between bench science in the laboratory and the doctor’s office by teaching effective, in-office regenerative medicine techniques.

Global Stem Cells Group to Move Headquarters to Larger Miami Lakes Office Complex

Global Stem Cells Group has announced plans to move its expanding network of stem cell and regenerative medicine companies to larger offices in the Miami Lakes Corporate Center.

Citing fast-paced growth and the need for more space to accommodate its expanding operations, Global Stem Cells Group CEO Benito Novas has announced plans to move the organization’s headquarters from Sunrise, Florida to the Miami Lakes Corporate Center. The new location more than doubles the space for the international stem cell and regenerative medicine company’s corporate offices.

Since opening in 2012 under the Regenestem brand, Global Stem Cells Group and its six operating companies have grown exponentially, establishing partnerships with stem cell clinics, hospitals, researchers and physicians in the Philippines, South America and Europe.

“The new Global Stem Cells Group facility provides state-of-the-art space for our entire team to drive innovation through our research and development initiatives, and support partnering activities with our biotechnology products and education programs,” Novas says. “We now have the space to continue the fast-paced growth of our companies and advance the development of new stem cell and regenerative medicine technologies that will benefit patients worldwide.”

The new corporate headquarters, scheduled to open January 15, 2015, are located in the Miami Lakes Corporate Center, 14750 NW 77th Court, Suite 304 Miami Lakes, FL 33016.

Global Stem Cells Group Launches Stem Cell Conference Website Page for At-a-Glance Meeting and Conference information

Global Stem Cells Group has launched a new website page, stemcellconference.org, designed as a platform for medical professionals looking for information on GSCG and Regenestem conference schedules and meetings worldwide.

Upcoming events already accessible through stemcellconference.org include the Global Stem Cells Group Regenerative Medicine Symposiums to be held Sept. 3 in Santiago, Chile; Oct. 9 in Barcelona, Spain; Oct. 15 in Buenos Aires, Argentina; and March 19, 2016 in San Jose, Costa Rica.

The StemCellsConference.org page provides comprehensive details on all upcoming Global Stem Cells Group events, bios on GSCG Regenerative Medicine Symposium faculty members and presenters, product developers and other affiliates in the field of regenerative medicine, conference agendas, conference exhibitors, sponsors and partners, and more.

For more information, visit stemcellconference.org, or the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.

About the Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group Subsidiary Stem Cell Training Announces Training Course to Take Place in Porto Alegre, Brazil

STEM CELL TRAINING, INC. AND CO-SPONSOR JORGE GIOSCIA FILHO,M.D. ANNOUNCE PLANS TO CONDUCT THE FIRST STEM CELL TRAINING COURSE IN BRAZIL OCT. 24-25, 2015. THE TRAINING CLASS WILL BE HELD IN PORTO ALEGRE.

stem cell therapies,EuroMedicom,stem cell medicine,global stem cells group,medical tourism,regenestem,

Stem Cell Training

Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.

Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced plans to conduct Brazil’s first ever stem cell harvesting and reintegration course Oct. 24 and 25, 2015. Through his alliance with Stem Cell Training, Inc. cardio-vascular surgeon Jorge Gioscia Filho, M.D. will conduct the Adipose and Bone Marrow Stem Cell Training Course for medical professionals in his home town of Poro Alegre.

In addition to his work in vascular and endovascular surgery, Filho has specialized in medical genital aesthetics in his private practice for more than 10 years. He is a member and professor at the Postgraduate Course in Aesthetic Medicine of IAAM-ASIME. Member of the International Society for Sexual Medicine and Vice President of the Southern Region of the Brazilian Society for Sexual Medicine, a member of the Brazilian Society of Angiology and Vascular Surgery, and a member of the International Society for Endovascular Specialists.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process through an intensive, hands-on training session to arm participating physicians with clinical protocols and state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells.

The objective of the training is to bridge the gap between bench science in the laboratory and the doctor’s office by teaching effective, in-office regenerative medicine techniques.

Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.
For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About Stem Cell Training, Inc.:

Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide

Global Stem Cells Group Announces Plans to Hold International Symposium on Stem Cells and Regenerative Medicine in Santiago, Chile Sept. 3-4, 2015

The Global Stem Cells Group, Inc. has announced plans to host an international symposium on stem cells and regenerative medicine in Santiago, Chile Sept. 3-4, 2015. The Chile symposium is one of four to be hosted by GSCG this year in Latin America.
stemlab,stem cells, stem cell therapies,liposculpture,plastic surgery

Global Stem Cells Group

The symposium will feature some of the world’s most prominent scientific experts in stem cell and regenerative medicine.

Global Stem Cells Group has announced plans to host an international symposium on stem cell research in Santiago, Chile. The symposium will feature some of the world’s most prominent scientific experts in stem cell and regenerative medicine, who will provide a full day of high-level scientific discussion for medical professionals in general practice.

The symposium agenda will include sessions on:

  • Molecular biology
  • Clinical advances in stem cell research
  • Models of treatment in surgical and cosmetic applications, and in clinical conditions
  • Technological advances
  • Application of minimally manipulated stem cells in the physician’s office
  • Stem cells, regenerative medicine and its application in anti-aging medicine
  • Medical legal issues

The Santiago, Chile symposium includes a full day, hands-on training session to provide participating physicians and qualified medical professionals with state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells, along with clinical protocols. This popular training course is part of the Global Stem Cells Group’s commitment to the growing network of world-class stem cell researchers, treatment practitioners and investors committed to advancing stem cell medicine, and helping physicians bring treatments into the office for the benefit of patients.

The Santiago symposium will be held at Santo Tomas University in Santiago, Chile, and hosted by the Dean of Health Services Faculty, Fernando Espina Otero, M.D.

For more information on the Global Stem Cells Group Santiago, Chile symposium including the lineup of speakers, visit the stemcellconference.org website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.

About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group to Participate in the 15th International Congress of Aesthetic Surgery in Boca del Rio, Veracruz

More than 1,500 aesthetic surgeons and specialists in the fields of anti-aging and regenerative medicine from around the globe will attend the four day event.

Charles Mahl, M.D. and David B. Audley will representGlobal Stem Cells Group, Inc. as keynote speakers at the 15th International Congress of Aesthetic Surgeryin Boca del Rio in Veracruz, Mexico July 9-12, 2015. Mahl, a member of the Global Stem Cells Group Scientific Advisory Board, and Audley, the chairman and general secretary of the Regentech Alliance (RTA), will join more than 1,500 aesthetic surgeons and specialists in the fields of anti-aging and regenerative medicine from around the globe for the four day event.

Hosted by the Instituto de Estudios Superiores en Medicina (Institute of Advanced Studies in Medicine) in Veracruz, conference attendees will include an international lineup of physicians and medical practitioners in a variety of disciplines who will gather to discuss the newest therapies, protocols and innovative procedures available in aesthetic medicine.

Mahl, who maintains an active practice in regenerative medicine, preventive aging and pain therapies, will bring his expertise in prolotherapy, platelet rich plasma injections and stem cell therapies to the conference. Audley is a pioneer in the field of regenerative medicine and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies.

The conference will feature workshops in botulinum toxin applications for beginners and advanced students, and peeling treatments for stretch marks. Some of the topics to be addressed at the event include updates in aesthetic surgery, regenerative medicine therapies, platelet rich plasma applications, clinical and therapeutic stem cell applications, facial fillings, COFEPRIS guidelines, legal issues associated with aesthetic surgery and more.

The conference will take place at the Hotel Galerias Plaza Veracruz, Blvd. Adolfo Ruiz Cortines #3495, Costa Verde, Boca Del Río, Veracruz. For more information on the 15th International Congress of Aesthetic Surgery, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com or call 305-560-5337.

About Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

About Charles Mahl, M.D.:

Charles F. Mahl, M.D. is a Miami-based specialist in regenerative medicine, preventive aging and pain therapies. His expertise includes prolotherapy, platelet rich plasma injections and stem cell therapies for a variety of painful orthopedic conditions and injuries involving (but not limited to) the back, sacroiliac joints, hips, knees, shoulders and neck. Mahl’s background as a vitreo-retinal surgeon prior to his training in regenerative medicine makes him eminently qualified to perform stem cell therapies on the eyes.

A member of the Global Stem Cells Group Scientific Advisory Board, Mahl sees stem cell therapies as medicine’s new frontier, offering unlimited possibilities for easing and eliminating many forms of disease and injury-related pain. He is licensed to practice medicine in Florida and Board Certified in Integrative Medicine. Mahl has completed multiple fellowships in age management medicine, and spent more than two years in a mentorship program for prolotherapy and regenerative injection medicine with Alvin Stein, M.D., a relationship that continues to this day. For Mahl’s full bio, visit http://www.stemcellsgroup.com/advisory-board/.

About David B. Audley:

David B. Audley serves as the Chair and General Secretary of the Regentech Alliance (RTA), a 501(c)3 backed by individuals and institutions who support the Regentech mission to bring peer oversight and transparency to the field of cell-based and regenerative medicine. Audley is a pioneer in the emerging field of regenerative medicine, and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies. Audley has taken a leadership role in drafting international standards and governmental regulations for the Cayman Islands and the Bahamas, and has worked with regulators in Mexico, the Kingdom of Jordan, and China to provide frameworks for physicians. Audley is a well-known lecturer who has spoken widely on varying topics dealing with the trends in patient care, the importance of oversight for investigational therapies, the emergence of regenerative medicine and the global and regulatory issues associated with medical tourism. For more information, visit http://regen-tech.org.

Global Stem Cells Group, Stem Cell Training and Anti-aging Medicine Specialist John P. Salerno, M.D. to Hold Training Course in Manhattan

The course will focus on stem cell therapies for a variety of conditions and treatments including anti-aging therapies.

MIAMI (PRWEB) June 08, 2015

Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced plans to conduct a hands-on, two day intensive stem cell training course for physicians and qualified medical professionals Sept. 18 -19, 2015. The training course will be led by anti-aging specialist John P. Salerno, M.D. in Midtown Manhattan.

The founder of The Salerno Center, Salerno practices integrative medicine, combining traditional and alternative healing methods. The course will focus on stem cell therapies for a variety of conditions and treatments including anti-aging therapies. Salerno trained in anti-aging medicine and has opened more than 20 anti-aging medical centers worldwide, including 10 in Japan, three in Brazil and two in Korea.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process through an intensive, hands-on training session that arms participants with clinical protocols and state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells.

The objective of the training is to teach effective regenerative medicine techniques that can be used to treat patients in-office.

Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.
For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About Stem Cell Training, Inc.:

Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.

About John P. Salerno, M.D.:

The go-to doctor for professional, comprehensive and full-service care, John P. Salerno, M.D. offers life-changing health solutions and educates both patients and physicians on the benefits of health, wellness and complementary medicine with a specialized focus in vitamin IV therapy, heavy metal detox, weight loss, anti-aging medicine, allergies and hair loss. A former partner of the late Robert C. Atkins, M.D. of “The Atkins Diet” fame, Salerno created and developed his own award-winning diet called “The Silver Cloud Diet,” launching a worldwide movement for patients and physicians to grow, heal, and learn.

Salerno’s cutting-edge medical approach incorporates observation and state-of-the-art testing, enabling him to pioneer an exclusive treatment plan that is restorative and beneficial. Salerno is the author of two top-selling diet and lifestyle books,“Fight Fat with Fat” and “The Salerno Solution,” as well as a popular lecturer, radio host and global media icon.

Global Stem Cells Group and Marina Medical Announce Agreement to Conduct Stem Cell Training Courses Worldwide

Global Stem Cells Group and Marina Medical, Inc. announce plans to conduct joint stem cell training courses worldwide. GSCG subsidiary Adimarket will distribute stem cell products to Latin America in conjunction with the joint training program.

 

Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries.

MIAMI, June 4, 2015—Global Stem Cells Group and Marina Medical, Inc. have announced plans to conduct joint stem cell training courses for physicians and qualified medical professionals worldwide. Sunrise, Florida-based Marina Medical is an established leader in design, manufacture and distribution of medical devices for OBGYN, plastic and aesthetic surgery, regenerative medicine and urogynecology.

Marina Medical’s recently launched Koume Cannalus division manufactures instruments for regenerative medicine procedures. Teaming with GSCG for the stem cell training courses will help to further stem cell education among those medical professionals who use Marina Medical instruments.

Global Stem Cells Group subsidiary Adimarket will provide regenerative medicine equipment and supplies for the joint training session held in Latin America.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process of isolating and re-integrating adipose- and bone marrow-derived stem cells through an intensive, hands-on training session. The objective is to arm participating physicians with clinical protocols and state-of-the-art techniques so that they can bring regenerative medicine therapies to their patients in-office.

Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.
For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine. Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. Each of GSCG’s six operating companies focus on a separate research-based mission; the result is a global network of state-of-the-art stem cell treatments and facilities.

About Marina Medical, Inc.:

Since 1998, Marina Medical has been an established leader in the design, development and distribution of surgical instrumentation for OBGYN and plastic surgery. Customers receive access to educational materials, special offers, a rewards program, residents’ program and innovative surgical instrumentation and equipment. Through its newKoume Cannula division, Marina Medical manufactures instruments designed specifically for regenerative medicine procedures.

About Adimarket:

Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.

Adimarket was founded to provide physicians and other health care professionals the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact the practice of stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting edge treatments.

Global Stem Cells GroTurkeyup subsidiary Stem Cell Training Announces First Training Course to Take Place in Turkey

Global Stem Cell Training, Inc. announces plans to conduct the first stem cells harvesting and reintegration training course in Turkey Sept. 15 and 16, 2015. The training course will be held in Istanbul and lead by world renowned plastic surgeon Tunc Tiryaki, M.D.

Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced plans to conduct Turkey’s first ever stem cell

Tunv Tryak, M.D.

Tunv Tryak, M.D.

harvesting and reintegration course Sept 15 and 16, 2015. Through his alliance with Stem Cell Training, Inc. and in conjunction with medical device manufacturer Marina Medical, Tunc Tiryaki, M.D. will conduct the Adipose and Bone Marrow Stem Cell Training Course for medical professionals in Istanbul.
Tiryaki, a renowned plastic surgeon practicing in London and Istanbul, is a pioneer in cell enriched fat transfer. The course will focus on stem cell therapies for cosmetic/aesthetic conditions.
The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process through an intensive, hands-on training session to arm participating physicians with clinical protocols and state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells.
The objective of the training is to bridge the gap between bench science in the laboratory and the doctor’s office by teaching effective, in-office regenerative medicine techniques.
Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.
For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.
The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.

###

Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania

Stem Cell Training, Inc., a subsidiary of Global Stem Cells Group, announces plans to conduct the first stem cell training course in Romania Nov. 27-28, 2015. The training class will be held in Bucharest and lead by Cosmetic Surgeon Morad Iancu, M.D.

Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced plans to conduct Romania’s first ever stem cells harvesting and reintegration course Nov. 27-28, 2015. Through an alliance with Miami-based Stem Cell Training, Inc., Cosmetic Surgeon Morad Iancu, M.D. will conduct the Adipose and Bone Marrow Stem Cell Training Course for medical professionals in Bucharest.
Iancu is a reconstructive plastic surgery specialist practicing in Bucharest and Tel Aviv, Israel, and a popular “celebrity doctor” in Eastern Europe.
The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process of isolating and re-integrating adipose- and bone marrow-derived stem cells through an intensive, hands-on training session. The objective is to arm participating physicians with clinical protocols and state-of-the-art regenerative medicine techniques so that they can bring regenerative medicine therapies to their patients in-office. Iancu will focus the training session on stem cell treatments in cosmetic applications.
Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.
For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.
The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.

1 11 12 13 14 15 17